Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-10-04

Clinical Trial Update: Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)

View source ↗

Summary

Clinical trial update seeking additional information on the use of CorMatrix ECM for coronary disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CorMatrix ECM (extracellular matrix) (CorMatrix ECM)

Snippet

Sponsor: Elutia Inc. | Conditions: Coronary Disease | Status: COMPLETED | Results posted: 2019-10-04